CD274 and pancreatic neoplasm: Our previous studies have established OSCSCs as oral and MP2 as pancreatic stem-like/poorly differentiated tumors and OSCCs and PL12 tumors as well-differentiated oral and pancreatic tumors, respectively using CD44, CD54, MHC-class I, and PD-L1 surface antigens [62,70].